Upon comparing CD73+ and CD73-γδ1 T cells that were freshly isolated from human BC tissues, we first showed that the CD73+ subpopulation had greater immunosuppressive capacity to inhibit CD3+ T-cell proliferation and CD4+ and CD8+ T-cell function. This evidence concerns the gene CD4 and breast cancer.